Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Dynamic Map, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Loss Widens
336A Dynamic Map Platform Co.,Ltd. 【J-GAAP】
Earnings ReportDynamic Map Platform Co.,Ltd. <336A> [TSE Growth] announced its financial results after the market closed on February 13th (15:31). The consolidated ordinary loss for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded to a loss of 2.09 billion yen (compared to a loss of 1.53 billion yen in the same period last year).
In the most recent three-month period, from October to December (3Q), the consolidated ordinary loss expanded to a loss of 1.02 billion yen (compared to a loss of 0.12 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -6.4% in the same period last year to -108.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2024 | 4,012 | -1,421 | -1,530 | -1,538 | -81.8 | ー | Mar 27, 2025 | J-GAAP |
| Apr - Dec, 2025 | 3,373 | -2,145 | -2,098 | -2,237 | -94.7 | ー | Feb 13, 2026 | J-GAAP |
| YoY | -15.9% | -51.0% | -37.1% | -45.4% | -15.9% |
Guidance Update
Second Half Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2025 Prev | 4,549 | ー | ー | ー | - | 0 | Nov 13, 2025 | J-GAAP |
| Oct - Mar, 2025 New | 3,049 | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| Revision Rate | -33.0% | - | - | - | - |
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2026 Prev | 7,000 | ー | ー | ー | - | 0 | May 14, 2025 | J-GAAP |
| Mar, 2026 New | 5,500 | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| Revision Rate | -21.4% | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 5,217 | 89 | -5 | -128 | -6.8 | 0 | May 14, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 3,049 | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| YoY | -41.6% | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 | 7,465 | -1,219 | -1,414 | -1,544 | -81.8 | 0 | May 14, 2025 | J-GAAP |
| Mar, 2026 Guidance | 5,500 | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| YoY | -26.3% | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 1,764 | -113 | -121 | -122 | -6.5 | -6.4 | Mar 27, 2025 | J-GAAP |
| Jan - Mar, 2025 | 3,453 | 202 | 116 | -6 | -0.3 | 5.8 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 1,459 | -196 | -223 | -285 | -12.1 | -13.4 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 992 | -946 | -850 | -878 | -37.2 | -95.4 | Nov 13, 2025 | J-GAAP |
| Oct - Dec, 2025 | 922 | -1,003 | -1,025 | -1,074 | -45.5 | -108.8 | Feb 13, 2026 | J-GAAP |
| YoY | -47.7% | -787.6% | -747.1% | -780.3% | -601.7% |
Related Articles
TAIKO PHARMA, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 8% Increase in The Current Fiscal Year, Resuming Dividends at 3.3 Yen for the First Time in five terms., This Fiscal Year to Increase Dividend by 0.2 Yen
MS&AD Insurance, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%, Exceeds Full-Year Plan
Neural Group, Last Fiscal Year's Ordinary Profit Turns to Loss, Current period performance is undisclosed.
BrightPath Biotherapeutics, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
VELTRA, 3.7 times Increase in Ordinary Profit for The Current Fiscal Year
LIFE CREATE, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 41% Decrease
Asia Air Survey, Oct-Dec (1Q) Operating Profit Turns to Profit
Solvvy, First Half Ordinary Profit Increases by 22%, Oct-Dec Ordinary Profit Increases by 77%
OPTIMUS GROUP, Undisclosed Pretax Income to Reach 5.9 Billion Yen for The Current Fiscal Year
STI Foods Holdings, Last Fiscal Year's Ordinary Profit Unexpectedly Declines, 0.04% Decrease in The Current Fiscal Year